Successful treatment of pyoderma gangrenosum associated with myelodysplastic syndrome using high-dose intravenous immunoglobulin

Internal Medicine

Volumn 47, Issue 23, 2008, Pages 2077-2081

  Tamaki, Kenichiro ^a   Nakazawa, Takashi ^a,b   Mamehara, Akira ^a   Tsuji, Goh ^a   Saigo, Katsuyasu ^a   Kawano, Seiji ^a   Morinobu, Akio ^a,b   Kumagai, Shunichi ^a,b  

^a KOBE UNIVERSITY HOSPITAL   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Intravenous immunoglobulin; Myelodysplastic syndrome; Pyoderma gangrenosum

Indexed keywords

CYCLOSPORIN A; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE; STEROID;

ADULT; ARTICLE; CASE REPORT; DAILY LIFE ACTIVITY; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEVER; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; MAINTENANCE THERAPY; MALE; MYELODYSPLASTIC SYNDROME; NEUTROPHIL CHEMOTAXIS; PAIN; PANCYTOPENIA; PATIENT TRANSPORT; PYODERMA GANGRENOSUM; SKIN BIOPSY; ULCER;

HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PYODERMA GANGRENOSUM; TREATMENT OUTCOME;

EID: 61749093566     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.1280     Document Type: Article

References (22)

1. Gupta AK, Shear NH, Sauder DN. Efficacy of human intravenous immune globulin in pyoderma gangrenosum. J Am Acad Dermatol 32: 140-142, 1995.
2. Dirschka T, Kastner U, Behrens S, Altmeyer P. Successful treatment of pyoderma gangrenosum with intravenous human immunoglobulin. J Am Acad Dermatol 39: 789-790, 1998.
3. Hagman JH, Carrozzo AM, Campione E, Romanelli P, Chimenti S. The use of high-dose immunoglobulin in the treatment of pyoderma gangrenosum. J Dermatolog Treat 12: 19-22, 2001.
4. Budde M, Gusek-Schneider GC, Mayer U, Seitz B. Annular crystalline keratopathy in association with immunoglobulin therapy for pyoderma gangrenosum. Cornea 22: 82-85, 2003.
5. Dobson CM, Parslew RA, Evans S. Superficial granulomatous pyoderma treated with intravenous immunoglobulin. J Am Acad Dermatol 48: 456-460, 2003.
6. Swale VJ, Saha M, Kapur N, Hoffbrand AV, Rustin MH. Pyoderma gangrenosum outside the context of inflammatory bowel disease treated successfully with infliximab. Clin Exp Dermatol 30: 134-136, 2005.
7. Meyer N, Ferraro V, Mignard MH, Adamski H, Chevrant-Breton J. Pyoderma gangrenosum treated with high-dose intravenous immunoglobulins: Two cases and review of the literature. Clin Drug Investig 26: 541-546, 2006.
8. Zhang XB, He YQ, Zhou H, Luo Q, Li CX. A case of pyoderma gangrenosum responding to high-dose intravenous immunoglobulin therapy. Chin Med J 2006 20: 1230-1232, 2006.
9. Suchak R, Macedo C, Glover M, Lawlor F. Intravenous immunoglobulin is effective as a sole immunomodulatory agent in pyoderma gangrenosum unresponsive to systemic corticosteroids. Clin Exp Dermatol 32: 205-207, 2007.
10. Cummins DL, Anhalt GJ, Monahan T, Meyerle JH. Treatment of pyoderma gangrenosum with intravenous immunoglobulin. Br J Dermatol 157: 1235-1239, 2007.
11. Jolles S, Hughes J. Use of IGIV in the treatment of atopic dermatitis, urticaria, scleromyxedema, pyoderma gangrenosum, psoriasis, and pretibial myxedema. Int Immunopharmacol 6: 579-591, 2006.
12. Ehling A, Karrer S, Klebl F, Schaffler A, Muller-Ladner U. Therapeutic management of pyoderma gangrenosum. Arthritis Rheum 2004 50: 3076-3084, 2004.
13. Reichrath J, Bens G, Bonowitz A, Tilgen W. Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol 2005 53: 273-283, 2005.
14. Ahmadi S, Powell FC. Pyoderma gangrenosum: uncommon presentations. Clin Dermatol 23: 612-620, 2005.
15. Roy DB, Conte ET, Cohen DJ. The treatment of pyoderma gangrenosum using etanercept. J Am Acad Dermatol 54: S128-S134, 2006.
16. Pastor N, Betlloch I, Pascual JC, Blanes M, Banuls J, Silvestre JF. Pyoderma gangrenosum treated with anti-TNF alpha therapy (etanercept). Clin Exp Dermatol 31: 152-153, 2006.
17. Simon HU, Spath PJ. IVIG - mechanisms of action. Allergy 58: 543-552, 2003.
18. Sewell WA, Jolles S. Immunomodulatory action of intravenous immunoglobulin. Immunology 107: 387-393, 2002.
19. Su WP, Davis MD, Weenig RH, Powell FC, Perry HO. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol 43: 790-800, 2004.
20. Su WP, Schroeter AL, Perry HO, Powell FC. Histopathologic and immunopathologic study of pyoderma gangrenosum. J Cutan Pathol 13: 323-330, 1986.
21. Yamauchi T, Ishida K, Iwashima Y, et al. Successful treatment of pyoderma gangrenosum that developed in a patient with myelodysplastic syndrome. J Infect Chemother 9: 268-271, 2003.
22. Koca E, Duman AE, Cetiner D, et al. Successful treatment of myelodysplastic syndrome-induced pyoderma gangrenosum. Neth J Med 64: 422-424, 2006.